Antiangiogenic therapy in human gastrointestinal malignancies.
about
Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancers.Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway.Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition.
P2860
Antiangiogenic therapy in human gastrointestinal malignancies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antiangiogenic therapy in human gastrointestinal malignancies.
@ast
Antiangiogenic therapy in human gastrointestinal malignancies.
@en
type
label
Antiangiogenic therapy in human gastrointestinal malignancies.
@ast
Antiangiogenic therapy in human gastrointestinal malignancies.
@en
prefLabel
Antiangiogenic therapy in human gastrointestinal malignancies.
@ast
Antiangiogenic therapy in human gastrointestinal malignancies.
@en
P2093
P2860
P356
P1433
P1476
Antiangiogenic therapy in human gastrointestinal malignancies.
@en
P2093
D G Binion
J Heidemann
T Kucharzik
W Domschke
P2860
P304
P356
10.1136/GUT.2005.088229
P407
P577
2006-10-01T00:00:00Z